Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant (Pleural) Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Testing effectiveness (Phase 2)Study completedNCT01024946
What this trial is testing

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT07449624
What this trial is testing

From Presentation to Diagnosis: Patterns of Pleural Effusion

Who this might be right for
Pleural Mesothelioma
Mansoura University Hospital 300
Not applicableUnknownNCT05042557
What this trial is testing

Real World Study of MPM in China

Who this might be right for
Malignant Pleural MesotheliomaDiagnoses DiseaseTreatments+1 more
Chinese Academy of Medical Sciences 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT01843374
What this trial is testing

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

Who this might be right for
Unresectable Pleural or Peritoneal Malignant Mesothelioma
MedImmune LLC 571
Not applicableLooking for participantsNCT06886672
What this trial is testing

Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS

Who this might be right for
Mesothelioma, Malignant Pleural
Fondazione IRCCS Policlinico San Matteo di Pavia 60
Testing effectiveness (Phase 2)Study completedNCT00541073
What this trial is testing

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
Centre Oscar Lambret 60
Early research (Phase 1)Looking for participantsNCT06251310
What this trial is testing

SW-682 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMesothelioma, Malignant
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 186
Early research (Phase 1)Study completedNCT00299962
What this trial is testing

Gene Therapy for Pleural Malignancies

Who this might be right for
Pleural MesotheliomaMetastatic Pleural Effusions
University of Pennsylvania 17
Testing effectiveness (Phase 2)Study completedNCT01486368
What this trial is testing

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
NCIC Clinical Trials Group 17
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Early research (Phase 1)Study completedNCT04153565
What this trial is testing

Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

Who this might be right for
Mesothelioma
Merck Sharp & Dohme LLC 19
Not applicableStudy completedNCT02467426
What this trial is testing

Isolated Thoracic Perfusion (ITP-F) for MPM

Who this might be right for
Mesothelioma
Medias Klinikum for Surgical Oncology 23
Early research (Phase 1)Study completedNCT04525859
What this trial is testing

Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Oncovir, Inc. 19
Large-scale testing (Phase 3)Study completedNCT02991482
What this trial is testing

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 144
Testing effectiveness (Phase 2)Study completedNCT02049060
What this trial is testing

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Who this might be right for
Malignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung
Armando Santoro, MD 31
Next Page